We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Post-Mensing "Immunity" Under the Louisiana Products Liability Act: Johnson v. Teva Phaimaceuticals USA, Inc., and Its Implications for Louisiana Law.
- Authors
Quin, Justin P.
- Abstract
The article discusses the U.S Court of Appeals for the Fifth Circuit decision in case Johnson v. Teva Phaimaceuticals USA Inc. that addressed the plaintiff's design-defect claim against the generic manufacturer Teva Phaimaceuticals USA Inc. Topics discussed include the U.S Supreme Court's decision in case PLIVA, Inc. v. Mensing and Mutual Pharmaceutical Co. v. Bartlett, and the dismissal of the plaintiff's claims by the district court against the brand-name manufacturers.
- Subjects
DESIGN defects; TEVA Pharmaceuticals USA Inc.; UNITED States. Court of Appeals (5th Circuit); PLIVA Inc. v. Mensing (Supreme Court case); MUTUAL Pharmaceutical Co. v. Bartlett; ACTIONS &; defenses (Law)
- Publication
Tulane Law Review, 2015, Vol 89, Issue 4, p959
- ISSN
0041-3992
- Publication type
Article